COMP <GO>
PDEX vs UNH // GROSS PROFIT MARGIN
Pro-Dex Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PDEX 5
— UNH 8
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $61.60 (-2.52%) • MKT CAP: $199.2M
gross-margins
29.30%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDEX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDEX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 29.30% | 88.57% | -59.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.20% | 11.47% | +11.73 | PDEX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 16.4x | +0.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | -1.47% | 6.48% | -7.95 | UNH | /fcf-yield <GO> |
| Operating Margin | 16.10% | 4.82% | +11.28 | PDEX | /operating-margins <GO> |
| Net Profit Margin | 13.50% | 3.14% | +10.36 | PDEX | /net-margins <GO> |
| Revenue Growth (YoY) | 23.70% | 6.46% | +17.24 | PDEX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.08 | 3.12 | +5.96 | PDEX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 59.2 | -11.50 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.6x | 17.7x | +0.86 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $199.2M | $368.83B | -$368.63B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDEX REV | UNH REV | PDEX GROSS % | UNH GROSS % | PDEX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $66.6M | $447.57B | 29.3% | 88.7% | -$2.9M | $16.07B |
| FY 2024 | $53.8M | $400.28B | 27.0% | 88.3% | $6.2M | $20.70B |
| FY 2023 | $46.1M | $371.62B | — | 89.6% | $5.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDEX // BETA —
UNH // BETA 0.33